Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03697967 |
Other study ID # |
2019-1594 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
March 1, 2019 |
Est. completion date |
November 1, 2021 |
Study information
Verified date |
April 2022 |
Source |
Maisonneuve-Rosemont Hospital |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This study is conducted to evaluate if the prone position of the newborn on the chest of his
mother at birth before delayed cord clamping leads to better hematocrit and hemoglobin at
24-48 hours of life compared to supine position.
Description:
At 30 hours of life, laboratory personnel drew a capillary sample from the infant's heel for
hemoglobin, hematocrit, and total serum bilirubin at the same time as the newborn metabolic
screening sample. There is no added heelstick to routine care, as current standard in our
institution requires the bilirubin to be drawn at 30 hours of life.
During universal screening for congenital cardiac defects (30 hours of life), a value of
cerebral saturation (CrSO2) is measured using NIRS with INVOS (In Vivo Optical Spectroscopy,
INVOS System, Covidien, Dublin, Ireland, Somanetics). Sensors are placed over the forehead
and the newborn is in supine position.